Robert Stoffel

Robert Stoffel is currently the Vice President of Research at Amgen, where they drive strategy and oversee research activities in Rare Disease, Genetic Medicine, Hybrid Modalities, and Strategic Technology Alliances. With extensive cross-functional team leadership experience in the pharmaceutical industry, Stoffel has specific expertise in antibody drug conjugates and small molecule drug discovery. They previously held roles at Bristol Myers Squibb and AbbVie, culminating in the position of Senior Director of Immunology Antibody Drug Conjugates. Stoffel completed a Doctor of Philosophy in Chemistry at Penn State University and a degree in Biochemistry at the University of Scranton.